Pacific Biosciences's total assets for Q2 2026 were $751.85M, a decrease of -3.90% from the previous quarter. DE:P09 total liabilities were $785.06M for the fiscal quarter, a 0.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.